| Funding Opportunity |
Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional) Apply for PAR 25 328
Funding Number: PAR 25 328
Agency: National Institutes of Health
Funding Amount: $5,000,000 |
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) Apply for RFA CA 23 016
Funding Number: RFA CA 23 016
Agency: National Institutes of Health
Funding Amount: $600,000 |
HEAL Initiative: Oral Complications Arising from Pharmacotherapies to Treat Opioid Use Disorders (R21 Clinical Trial Not Allowed) Apply for RFA DE 23 016
Funding Number: RFA DE 23 016
Agency: National Institutes of Health
Funding Amount: $250,000 |
Point-of-Care Technologies Research Network: Technology Research and Development Centers (TRDC) (U54 Clinical Trial Optional) Apply for PAR 22 203
Funding Number: PAR 22 203
Agency: National Institutes of Health
Funding Amount: $1,200,000 |
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed) Apply for PAR 21 332
Funding Number: PAR 21 332
Agency: National Institutes of Health
Funding Amount: Case Dependent |
Understanding Oral Human Papillomavirus (HPV) Infection, Acquisition, and Persistence in People Living with HIV (R01 Clinical Trial Not Allowed) Apply for RFA DE 22 003
Funding Number: RFA DE 22 003
Agency: National Institutes of Health
Funding Amount: Case Dependent |
Exploratory Studies to Investigate the Mechanisms of Interrelationship between Sleep and Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans Required) Apply for RFA DA 22 029
Funding Number: RFA DA 22 029
Agency: National Institutes of Health
Funding Amount: $250,000 |
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed) Apply for RFA CA 21 003
Funding Number: RFA CA 21 003
Agency: National Institutes of Health
Funding Amount: $200,000 |
Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed) Apply for PAR 20 304
Funding Number: PAR 20 304
Agency: National Institutes of Health
Funding Amount: $250,000 |
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) Apply for PAR 19 150
Funding Number: PAR 19 150
Agency: National Institutes of Health
Funding Amount: $200,000 |
NIDA Avant-Garde Award Program for HIV/AIDS and Drug Use Research (DP1, Clinical Trial Optional) Apply for RFA DA 18 019
Funding Number: RFA DA 18 019
Agency: National Institutes of Health
Funding Amount: $500,000 |
Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R01 Clinical Trial Optional) Apply for PA 18 004
Funding Number: PA 18 004
Agency: National Institutes of Health
Funding Amount: Case Dependent |
Phylodynamic Tracking of HIV Transmission (R01) Apply for PAR 17 048
Funding Number: PAR 17 048
Agency: National Institutes of Health
Funding Amount: $499,999 |
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) Apply for RFA CA 20 010
Funding Number: RFA CA 20 010
Agency: Department of Health and Human Services, National Institutes of Health
Funding Amount: Case Dependent |
Distance Learning and Telemedicine Grants. Apply for RUS 19 02 DLT
Funding Number: RUS 19 02 DLT
Agency: Department of Agriculture, Utilities Programs
Funding Amount: $500,000 |
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trials Optional) Apply for RFA CA 18 010
Funding Number: RFA CA 18 010
Agency: Department of Health and Human Services, National Institutes of Health
Funding Amount: $150,000 |
